相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells
Hilah Gal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines
Shingo Mitomo et al.
CANCER SCIENCE (2008)
EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance
Shi-Xu Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma
Aaron J. Schetter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism
Shuji Fujita et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
MicroRNA expression profiling using microarrays
Chang-Gong Liu et al.
NATURE PROTOCOLS (2008)
Real-time PCR quantification of precursor and mature microRNA
Thomas D. Schmittgen et al.
METHODS (2008)
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
John A. Foekens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy
Joanne B. Weidhaas et al.
CANCER RESEARCH (2007)
Let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis
Kentaro Inamura et al.
LUNG CANCER (2007)
The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non-small cell lung cancer
Shinichi Toyooka et al.
CLINICAL CANCER RESEARCH (2007)
Lung cancer in never smokers - a different disease
Sophie Sun et al.
NATURE REVIEWS CANCER (2007)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
Dennis Loeffler et al.
BLOOD (2007)
Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history
Mounia Mounawar et al.
CANCER RESEARCH (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?
H. Uramoto et al.
BRITISH JOURNAL OF CANCER (2007)
Epidermal growth factor receptor mutations in lung cancer
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2007)
RNAi therapeutics: a potential new class of pharmaceutical drugs
David Bumcrot et al.
NATURE CHEMICAL BIOLOGY (2006)
Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer
Jeffrey A. Engelman et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
N Yanaihara et al.
CANCER CELL (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
Y Hayashita et al.
CANCER RESEARCH (2005)
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
N Thatcher et al.
LANCET (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
RAS is regulated by the let-7 MicroRNA family
SM Johnson et al.
CELL (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways
R Sordella et al.
SCIENCE (2004)
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues
CG Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
J Takamizawa et al.
CANCER RESEARCH (2004)
Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255
S Tracy et al.
CANCER RESEARCH (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA
JX Li et al.
ONCOGENE (2003)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers
ER Zabarovsky et al.
ONCOGENE (2002)
Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors
M Lastowska et al.
GENES CHROMOSOMES & CANCER (2002)
分享论文
